Corvair vs Imbio PHA (4.0.0)
AI Verdict
Choose Corvair if…
Choose Corvair if your primary need is an AI-powered assistant for rapid and comprehensive interpretation of standard 10-second resting diagnostic ECGs. This tool is ideal for healthcare professionals seeking to quickly identify 35 cardiac determinations, including rhythm and morphology, to enhance clinical confidence in ECG analysis.
View Corvair →Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA if you require automated, AI-driven quantitative analysis of cardiac structures from CT pulmonary angiogram (CTPA) scans. This software is best suited for clinicians needing to quickly measure right and left ventricular diameters and ratios to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension.
View Imbio PHA (4.0.0) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Corvair | Imbio PHA (4.0.0) |
|---|---|---|
| Deployment | Cloud, Mobile App | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio PHA (4.0.0)Imbio PHA emphasizes seamless integration with native DICOM tools and workflows, delivering annotated images and summary reports directly into the PACS without additional steps for the physician. This focus on minimal disruption to existing clinical practices and fully automated results gives it an edge in usability. Corvair, while simplifying ECG acquisition with a 4-lead requirement, is an API, meaning its ultimate user experience is dependent on the integrating 'target device'.
Clinical Value
Imbio PHA (4.0.0)Both tools are FDA-cleared and offer significant clinical value. Imbio PHA provides critical, automated measurements from CTPA scans for the diagnosis and risk stratification of life-threatening conditions like pulmonary embolism and hypertension, standardizing an often inconsistent assessment. Corvair offers a broad range of 35 cardiac determinations from ECGs, including acute myocardial infarction, but Imbio's focused impact on critical, often time-sensitive, conditions and its ability to standardize reporting gives it a slight advantage.
Pricing & Value
TieBoth tools explicitly state 'contact vendor' or 'contact for pricing,' indicating a lack of transparent pricing information. Without specific cost details, it is impossible to conduct a head-to-head comparison of their financial value. Therefore, it is a tie in this dimension.
Enterprise Readiness
Imbio PHA (4.0.0)Imbio PHA offers superior enterprise readiness due to its flexible deployment options, including cloud, on-premise, or via partners, which caters to a wider range of institutional IT infrastructures and data security preferences. Corvair is solely cloud-based, which may not suit all enterprise requirements.
Innovation
CorvairCorvair demonstrates significant innovation by being an FDA-cleared AI capable of detecting 35 cardiac determinations, including heart attacks, using a reduced leadset (4 ECG leads for Corvair, or 5 electrodes for 8 leads in the related Kardia 12L system). This represents a pioneering approach to comprehensive ECG analysis from minimal input. While Imbio PHA is innovative in automating complex CTPA measurements, Corvair's breadth of detection from reduced input stands out.
Support & Docs
Imbio PHA (4.0.0)Imbio PHA provides clear and detailed information regarding its support channels, including phone and email contacts, an online case submission form, and readily available user manuals and product documentation online. AliveCor, while having general support for its ecosystem and an AI assistant, does not explicitly detail Corvair-specific support and documentation in the same direct manner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Corvair | Imbio PHA (4.0.0) |
|---|---|---|
| Tool Name | Corvair | Imbio PHA (4.0.0) |
| Company | AliveCor | Imbio |
| Primary Function | FDA-cleared AI ECG analysis system that assists healthcare professionals in interpreting resting diagnostic ECGs with 35 cardiac determinations. | FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. |
| Key Analysis/Measurements | Analyzes 10-second ECGs; Provides 35 cardiac determinations (14 rhythm, 21 morphology); Requires only 4 ECG leads for analysis. | Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios. |
| Input Data Type | Standard diagnostic-bandwidth ECG recordings (wet Ag/AgCl electrodes) | CT pulmonary angiogram (CTPA) scans |
| Output/Reporting | Automated interpretation reviewable by HCP | Generates annotated DICOM images; Provides summary reports in PDF format; Integrates with native DICOM tools and workflows. |
Videos
Demos, reviews, and walkthroughs featuring Corvair and Imbio PHA (4.0.0).
Frequently Asked Questions
More Comparisons
More matchups featuring Corvair or Imbio PHA (4.0.0)
Backers
Who funded each tool's parent company.